Response to Comment on: Bergenstal et al. A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin–Treated Patients With Type 2 Diabetes. Diabetes Care 2012;35:2140–2147

Detalles Bibliográficos
Autores principales: Bergenstal, Richard M., Rosenstock, Julio, Arakaki, Richard F., Prince, Melvin J., Qu, Yongming, Sinha, Vikram P., Howey, Daniel C., Jacober, Scott J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Online Letters: Comments and Responses
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687327/
https://www.ncbi.nlm.nih.gov/pubmed/23801809
http://dx.doi.org/10.2337/dc13-0295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687327/
https://www.ncbi.nlm.nih.gov/pubmed/23801809
http://dx.doi.org/10.2337/dc13-0295

Ejemplares similares